Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.
As of Nov 14, 2026, NDA 50622 (Suprax), held by Lederle, was first approved by FDA on Apr 28, 1989, with 20 approved supplements and 0 published complete response letters.
First approved: Apr 28, 1989
Review: Standard
Supplements approved: 20
Complete response letters: 0
Approvals and New Uses
The original application and every efficacy supplement, newest first; all 21 submissions below
Date
Submission
Status
Documents
Apr 28, 1989
Original applicationNew dosage form · Standard review
Approved
None posted
Products
1 strengths and forms
Product
Active ingredient
Marketing
Suprax100MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · for suspension;oral
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters.Drugs@FDA and FDA complete response letters
